Serum Biomarkers in Idiopathic Pulmonary Fibrosis

Pulmonary Pharmacology and Therapeutics - United States
doi 10.1016/j.pupt.2010.08.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis

Pulmonary Medicine
MedicinePulmonaryRespiratory Medicine
2011English

Idiopathic Pulmonary Fibrosis

Pulmonologiya
PulmonaryRespiratory Medicine
2015English

Idiopathic Pulmonary Fibrosis

2020English

Prognostic Value of Serum Osteopontin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2020English

Managing Comorbidities in Idiopathic Pulmonary Fibrosis

International Journal of General Medicine
Medicine
2015English

Cell Therapy in Idiopathic Pulmonary Fibrosis†

Medical Sciences
2018English

Cardiovascular Risk in Idiopathic Pulmonary Fibrosis

International Journal of Pulmonary & Respiratory Sciences
2018English

Idiopathic Pulmonary Fibrosis in Monozygotic Twins

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1980English

Epigenomics of Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy